0 followers
Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).
Elizabeth O'Day
Tango Therapeutics
2 followers
Caribou Biosciences
2 followers
VantAI
1 follower
Applied Therapeutics
1 follower
Ultima Genomics
3 followers
Thermo Fisher Scientific
176 followers
Regeneron
104 followers
Agilent Technologies
69 followers
Roivant Sciences
56 followers
GRAIL
27 followers
Ionis Pharmaceuticals
28 followers
Explore companies